Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2020

Open Access 01-12-2020 | Tenosynovitis | Study protocol

Platelet-rich plasma versus corticosteroid injection for treatment of trigger finger: study protocol for a prospective randomized triple-blind placebo-controlled trial

Authors: Samuli Aspinen, Panu H. Nordback, Turkka Anttila, Susanna Stjernberg-Salmela, Jorma Ryhänen, Jussi Kosola

Published in: Trials | Issue 1/2020

Login to get access

Abstract

Background

Trigger finger is a common hand disorder that limits finger range of motion and causes pain and snapping of the affected finger. Trigger finger is caused by an imbalance of the tendon sheath and the flexor tendon. The initial treatment is generally a local corticosteroid injection around the first annular (A1) pulley. However, it is not unusual that surgical release of the A1 pulley is required. Moreover, adverse events after local corticosteroid injection or operative treatment may occur. Platelet-rich plasma (PRP) has been shown to be safe and to reduce symptoms in different tendon pathologies, such as DeQuervain’s disease. However, the effects of PRP on trigger finger have not been studied. The aim of this single-center triple-blind randomized controlled trial is to study whether PRP is non-inferior to corticosteroid injection in treating trigger finger. The secondary outcome is to assess the safety and efficacy of PRP in comparison to placebo.

Methods

The trial is designed as a randomized, controlled, patient-, investigator-, and outcome assessor-blinded, single-center, three-armed 1:1:1 non-inferiority trial. The patients with clinical symptoms of trigger finger will be randomly assigned to treatment with PRP, corticosteroid, or normal saline injection. The primary outcome is Patient-Rated Wrist Evaluation and symptom resolution. Secondary outcomes include Quick-Disabilities of the Arm, Shoulder and Hand; pain; grip strength; finger active range of motion; and complications. Appropriate statistical methods will be applied.

Discussion

We present a novel RCT study design on the use of PRP for the treatment of trigger finger compared to corticosteroid and normal saline injection. The results of the trial will indicate if PRP is appropriate for the treatment of trigger finger.

Trial registration

ClinicalTrials.gov NCT04167098. Registered on November 18, 2019.
Literature
1.
Peters-Veluthamaningal C, van der Windt DA, Winters JC, Meyboom-de Jong B. Corticosteroid injection for trigger finger in adults. Cochrane Database Syst Rev. 2009;(1):CD005617.
2.
Gorsche R, Wiley JP, Renger R, Brant R, Gemer TY, Sasyniuk TM. Prevalence and incidence of stenosing flexor tenosynovitis (trigger finger) in a meat-packing plant. J Occup Environ Med. 1998;40:556–60.CrossRef
3.
Moore JS. Flexor tendon entrapment of the digits (trigger finger and trigger thumb). J Occup Environ Med. 2000;42:526–45.CrossRef
4.
Fiorini HJ, Tamaoki MJ, Lenza M, Gomes Dos Santos JB, Faloppa F, Belloti JC. Surgery for trigger finger. Cochrane Database Syst Rev. 201820;2(2):CD009860.
5.
Stahl S, Kanter Y, Karnielli E. Outcome of trigger finger treatment in diabetes. J Diabetes Complicat. 1997;11:287–90.CrossRef
6.
Makkouk AH, Oetgen ME, Swigart CR, Dodds SD. Trigger finger: etiology, evaluation, and treatment. Curr Rev Musculoskelet Med. 2007;1:92–6.CrossRef
7.
Blood TD, Morrell NT, Weiss AP. Tenosynovitis of the hand and wrist: a critical analysis review. JBJS Rev. 2016;29:4.
8.
Matthews A, Smith K, Read L, Nicholas J, Schmidt E. Trigger finger: an overview of the treatment options. JAAPA. 2019;32:17–21.CrossRef
9.
Lambert MA, Morton RJ, Sloan JP. Controlled study of the use of local steroid injection in the treatment of trigger finger and thumb. J Hand Surg Br. 1992;17:69–70.CrossRef
10.
Murphy D, Failla JM, Koniuch MP. Steroid versus placebo injection for trigger finger. J Hand Surg Am. 1995;20:628–31.CrossRef
11.
Peters-Veluthamaningal C, Winters JC, Groenier KH, Jong BM-D. Corticosteroid injections effective for trigger finger in adults in general practice: a double-blinded randomised placebo controlled trial. Ann Rheumatic Dis. 2007;67:1262–6.CrossRef
12.
Huisstede BM, Gladdines S, Manon S, Randsdorp MS, Koes BW. Effectiveness of conservative, surgical, and postsurgical interventions for trigger finger, Dupuytren disease, and De Quervain disease: a systematic review. Arch Phys Med Rehabil. 2018;99:1635–49.CrossRef
13.
Ma S, Wang C, Li J, Zhang Z, Yu Y, Lv F. Efficacy of corticosteroid injection for treatment of trigger finger: a meta-analysis of randomized controlled trials. J Investig Surg. 2019;32:433–41.CrossRef
14.
Amirfeyz R, McNinch R, Watts A, Rodrigues J, Davis TRC, Glassey N, Bullock J. Evidence-based management of adult trigger digits. J Hand Surg Eur Vol. 2017;42:473–80.CrossRef
15.
Fitzpatrick J, Bulsara M, Zheng MH. The effectiveness of platelet-rich plasma in the treatment of tendinopathy: a meta-analysis of randomized controlled clinical trials. Am J Sports Med. 2016;45:226–33.CrossRef
16.
Barile A, La Marra A, Arrigoni F, Mariani S, Zugaro L, Splendiani A, et al. Anaesthetics, steroids and platelet-rich plasma (PRP) in ultrasound-guided musculoskeletal procedures. BJR. 2016;89:20150355.CrossRef
17.
Peerbooms JC, Sluimer J, Bruijn DJ, Gosens T. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial. Am J Sports Med. 2010;38:255–62.CrossRef
18.
Singh P, Madanipour S, Bhamra JS, Gill I. A systematic review and meta-analysis of platelet-rich plasma versus corticosteroid injections for plantar fasciopathy. Int Orthopaedics (SICOT). 2017;41:1169–81.CrossRef
19.
Fitzpatrick J, Bulsara MK, O’Donnell J, Zheng MH. Leucocyte-rich platelet-rich plasma treatment of gluteus medius and minimus tendinopathy: a double-blind randomized controlled trial with 2-year follow-up. Am J Sports Med. 2019;47:1130–7.CrossRef
20.
Le ADK, Enweze L, DeBaun MR, Dragoo JL. Current clinical recommendations for use of platelet-rich plasma. Curr Rev Musculoskelet Med. 2018;11:624–34.CrossRef
21.
Redler A, Proietti L, Mazza D, Koverech G, Vadala A, De Carli A, Ferretti A. Rupture of the patellar tendon after platelet-rich plasma treatment: a case report. Clin J Sport Med. 2020;30:e20–2.PubMed
22.
23.
Brinks A, Koes BW, Volkers AC, Verhaar JA, Bierma-Zeinstra SM. Adverse effects of extra-articular corticosteroid injections: a systematic review. BMC Musculoskelet Disord. 2010;11:206.
24.
Bruijnzeel H, Neuhaus V, Fostvedt S, Jupiter JB, Mudgal CS, Ring DC. Adverse events of open A1 pulley release for idiopathic trigger finger. J Hand Surg. 2012;37:1650–6.CrossRef
25.
MacDermid JC, Turgeon T, Richards RS, Beadle M, Roth JH. Patient rating of wrist pain and disability: a reliable and valid measurement tool. J Orthop Trauma. 1998;12:577–86.
26.
Sandelin H, Jalanko T, Huhtala H, Lassila H, Haapala J, Helkamaa T. Translation and validation of the Finnish version of the patient-rated wrist evaluation questionnaire (PRWE) in patients with acute distal radius fracture. Scand J Surg. 2016;105:204–10.CrossRef
27.
Beaton DE, Wright JG, Katz JN. Development of the QuickDASH. J Bone Joint Surg. 2005;87:1038–46.PubMed
28.
Hacklin E, Timlin S, Madanat R, Strandberg N, Aro H. DASH-kyselykaavakkeen suomentaminen ja kulttuuriadaptaatio. Suomen Ortopedia ja Traumatologia. 2009;32:252–4.
29.
30.
Massy-Westropp N, Ahern M, Krishnan J. A visual analogue scale for assessment of the impact of rheumatoid arthritis in the hand: validity and repeatability. J Hand Ther. 2005;18:30–3.CrossRef
31.
Kapandji A. Clinical test of apposition and counter-apposition of the thumb. Ann Chir Main. 1986;5:67–73.CrossRef
32.
Walenkamp MM, de Muinck Keizer RJ, Goslings JC, Vos LM, Rosenwasser MP, Schep NW. The minimum clinically important difference of the patient-rated wrist evaluation score for patients with distal radius fractures. Clin Orthop Relat Res. 2015;473:3235–41.CrossRef
33.
Sorensen AA, Howard D, Tan WH, Ketchersid J, Calfee RP. Minimal clinically important differences of 3 patient-rated outcomes instruments. J Hand Surg Am. 2013;38:641–9.CrossRef
34.
Järvinen TLN, Sihvonen R, Bhandari M, Sprague S, Malmivaara A, Paavola M, et al. Blinded interpretation of study results can feasibly and effectively diminish interpretation bias. J Clin Epidemiol. 2014;67:769–72.CrossRef
35.
Azur MJ, Stuart EA, Frangakis C, Leaf PJ. Multiple imputation by chained equations: what is it and how does it work? Int J Methods Psychiatr Res. 2011;20:40–9.CrossRef
36.
Jones I, Togashi R, Thomas Vangsness C Jr. The economics and regulation of PRP in the evolving field of orthopedic biologics. Curr Rev Musculoskelet Med. 2018;11:558–65.CrossRef
37.
Man D, Plosker H, Winland-Brown JE. The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery. Plast Reconstr Surg. 2001;107:238–9.CrossRef
38.
Kia C, Baldino J, Bell R, Ramji A, Uyeki C, Mazzocca A. Platelet-rich plasma: review of current literature on its use for tendon and ligament pathology. Curr Rev Musculoskelet Med. 2018;11:566–72.CrossRef
39.
Chen X, Jones IA, Park C, Vangsness CT Jr. The efficacy of platelet-rich plasma on tendon and ligament healing: a systematic review and meta-analysis with bias assessment. Am J Sports Med. 2017;46:2020–32.CrossRef
40.
Malahias MA, Roumeliotis L, Nikolaou VS, Chronopoulos E, Sourlas I, Babis GC. Platelet-rich plasma versus corticosteroid intra-articular injections for the treatment of trapeziometacarpal arthritis: a prospective randomized controlled clinical trial. Cartilage. 2018;20:1947603518805230.
41.
Ramesh R, Jeyaraman M, Prajwal GS. The prospective study on efficacy and functional outcome of autologous platelet rich plasma injection in musculoskeletal disorders. EC Orthopaedics. 2018;9(12):849–63.
42.
Shahid M, Kundra R. Platelet-rich plasma (PRP) for knee disorders. EFORT Open Rev. 2017;2:28–34.CrossRef
Metadata
Title
Platelet-rich plasma versus corticosteroid injection for treatment of trigger finger: study protocol for a prospective randomized triple-blind placebo-controlled trial
Authors
Samuli Aspinen
Panu H. Nordback
Turkka Anttila
Susanna Stjernberg-Salmela
Jorma Ryhänen
Jussi Kosola
Publication date
01-12-2020
Publisher
BioMed Central
Keyword
Tenosynovitis
Published in
Trials / Issue 1/2020
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-020-04907-w

Other articles of this Issue 1/2020

Trials 1/2020 Go to the issue

Study protocol

A trauma medical home, evaluating collaborative care for the older injured patient: study protocol for a randomized controlled trial

Study protocol

Case management after acquired brain injury compared to care as usual: study protocol for a 2-year pragmatic randomized controlled superiority trial with two parallel groups

Study protocol

Acupuncture for primary fibromyalgia: Study protocol of a randomized controlled trial

Study protocol

Evaluating the myopia progression control efficacy of defocus incorporated multiple segments (DIMS) lenses and Apollo progressive addition spectacle lenses (PALs) in 6- to 12-year-old children: study protocol for a prospective, multicenter, randomized controlled trial

Study protocol

Clinical efficacy of ceramic versus resin-based composite endocrowns in Chinese adults: study protocol for a randomized controlled trial

Study protocol

An online-based intervention to promote healthy eating through self-regulation among children: study protocol for a randomized controlled trial